Evidence map›Paper›PMID 41922356›Full record

ArticleNature communications2026

An end-to-end generalizable deep learning framework to comprehensively analyze transcriptional regulation.

Zhaoxi Zhang, Xiaoya Fan, Jiaxin Zhong, Lijuan Jia, Yuanyuan Han, Chenyi Yang, Zengyou He, Xiaoyan Li, Shing-Tung Yau, Rongling Wu and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhaoxi ZhangSchool of Software Technology, Dalian University of Technology, Dalian, China.ORCID 0000-0002-3894-7641
Xiaoya FanSchool of Software Technology, Dalian University of Technology, Dalian, China.ORCID 0000-0002-5002-6968
Jiaxin ZhongSchool of Software Technology, Dalian University of Technology, Dalian, China.
Lijuan JiaSchool of Software Technology, Dalian University of Technology, Dalian, China.
Yuanyuan HanSchool of Software Technology, Dalian University of Technology, Dalian, China.ORCID 0000-0002-3440-0999
Chenyi YangSchool of Software Technology, Dalian University of Technology, Dalian, China.
Zengyou HeSchool of Software Technology, Dalian University of Technology, Dalian, China.
Xiaoyan LiDepartment of Pathology, Cancer Hospital of Dalian University of Technology, Shenyang, China.
Shing-Tung YauBeijing Key Laboratory of Topological Statistics and Applications for Complex Systems, Beijing Institute of Mathematical Sciences and Applications, Beijing, China.ORCID 0000-0003-3394-2187
Rongling WuBeijing Key Laboratory of Topological Statistics and Applications for Complex Systems, Beijing Institute of Mathematical Sciences and Applications, Beijing, China. ronglingwu@bimsa.cn.ORCID 0000-0002-2334-6421
Charles G DankoBaker Institute for Animal Health, Cornell University, Ithaca, NY, USA. cgd24@cornell.edu.ORCID 0000-0002-1999-7125
Zhong WangSchool of Software Technology, Dalian University of Technology, Dalian, China. wangzhong@bimsa.cn.ORCID 0009-0003-5602-1003

Funding

Dalian University of Technology (DUT) XLYC2002010
6 · The paper itself

Abstract

Genome annotation currently requires performing dozens of molecular assays in hundreds of cell and tissue samples, an expensive endeavor which is impractical to replicate across all species and conditions of interest. Here, we introduce BioSeq2Seq, a deep learning framework that infers cell-line-specific molecular assays widely used for genome annotation by leveraging a tri-modal input: evolutionarily conserved DNA sequence features, together with cell-line-specific transcriptional activity and directionality captured by a single run-on sequencing assay. BioSeq2Seq enables flexible genome annotation tasks through parameterized configurations of input features and output targets, combined with gradient-guided architectural refinement for specific biological objectives. Our model demonstrates high accuracy across four downstream tasks, showing improvements of 14.27% in histone modification prediction, 2.50% in functional element identification, and 2.90% in gene expression prediction compared to state-of-the-art methods. In transcription factor binding site (TFBS) prediction, it maintains performance comparable to that of leading existing approaches. By achieving competitive performance across tasks with single-cell-line input data, BioSeq2Seq provides an efficient and low-cost alternative for genome annotation.

Indexed as

Deep LearningGene Expression RegulationTranscription, GeneticAnimalsBinding SitesCell LineHumansMolecular Sequence AnnotationTranscription FactorsTranscription Factors

Identifiers

PMID41922356
PMCPMC13212934

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.